Showing all 4 results
Oxybutynin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE desiccant bottles to ensure the absolute chemical stability of the controlled-release hydrogel network.
Active Ingredient Strength Primary Clinical Function Oxybutynin Chloride USP/Ph.Eur. 5 mg (ER) Initiation Standard: Base once-daily titration unit for the gradual introduction of antimuscarinic therapy. Oxybutynin Chloride USP/Ph.Eur. 10 mg / 15 mg (ER) Global Clinical Standard: Advanced maintenance doses for severe, refractory Overactive Bladder and neurogenic detrusor overactivity. Excipients Hypromellose (HPMC) / Lactose Anhydrous / Macrogol (PEG) / Magnesium Stearate / Titanium Dioxide Hydrophilic Polymer Matrix / Diluent / Plasticizer / Premium Film-Coating (Engineered specifically to form a highly viscous external gel barrier upon swallowing, controlling the exact 24-hour drug diffusion rate) *Pack Sizes: Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-compliance 30-day chronic urology dispensing regimens).
Pancreatin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Tablet or Hard Capsule (containing Enteric Minimicrospheres), packed exclusively in highly secure, moisture-resistant Alu-Alu blisters or desiccant-lined HDPE bottles to ensure the absolute stability of the biological proteins.
Active Ingredient Strength (Standardized USP Units) Primary Clinical Function Pancreatin (Porcine Origin) Ph.Eur./USP 10,000 Lipase Units
(approx. 33,200 Protease / 33,200 Amylase)Pediatric / Initiation Standard: Base therapeutic unit for pediatric Cystic Fibrosis patients and meal-snack titration. Pancreatin (Porcine Origin) Ph.Eur./USP 25,000 Lipase Units
(approx. 85,000 Protease / 74,700 Amylase)Global Clinical Standard: High-dose adult maintenance therapy for severe Exocrine Pancreatic Insufficiency and Pancreatectomy. Excipients Methacrylic Acid Copolymer / Macrogol / Simethicone / Microcrystalline Cellulose / Triethyl Citrate Enteric Barrier Coating / Plasticizer / Anti-Foaming Agent / Diluent (Engineered specifically to protect the biological extract from gastric acid and ensure rapid, synchronized dissolution in the duodenum) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-volume daily dispensing where patients may consume 3 to 10 units daily with every meal and snack).
Pregabalin & Methylcobalamin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly light-sensitive B12 coenzyme and the SR polymer network.
Active Ingredient Strength Primary Clinical Function Pregabalin INN/Ph.Eur. 75 mg (Sustained-Release) 24-hour controlled suppression of neuropathic pain and hyperalgesia. Methylcobalamin (Mecobalamin) JP/USP 1500 mcg Global Clinical Standard: High-dose active B12 for the anatomical regeneration of the myelin sheath. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Titanium Dioxide / Magnesium Stearate Hydrophilic SR Polymer Matrix / Diluent / Glidant / UV-Blocking Film-Coating (Engineered to control the exact 24-hour diffusion rate while shielding the API from light degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic diabetology and neurology dispensing regimens).
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
